ArticleGels (Basel, Switzerland)2026
Frontal Polymerization-Enabled Rapid Fabrication of Gelatin-Containing Hydrogels with Good Mechanical and Biological Properties.
Article in Gels (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
A time-saving approach to gelatin-based hydrogels with versatile properties is highly desirable. Herein, we report the rapid fabrication of new gelatin-containing hydrogels with favorable mechanical properties, biocompatibility and antibacterial capability. Frontal polymerization (FP) of acrylic acid (AA), acrylamide (AM), hydroxypropyl acrylate (HPA) with gelatin methacryloyl (GelMA) enables the rapid formation of multifunctional hydrogels within 7 min, providing a highly efficient route for gelatin-based hydrogel fabrication. The effect of GelMA content on FP features and hydrogel properties was systematically investigated. The resultant hydrogels show attractive collective properties with tensile strength up to 101.3 kPa, elongation at break up to 227.7%, cell viability of 96% after 24 h, and antibacterial activity against
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.